Fairvalue-Calculator Fairvalue-Calculator
EN DE

Miwon Specialty Chemical Co (268280) Fair Value & Analysis

Basic Materials · KR · Market cap 480B KRW

Price97,700 KRW
Fair Value177,268 KRW
Upside+81.4%
Quality95/100
Evidence: High Range 110,285 KRW – 236,853 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Miwon Specialty Chemical Co (268280) currently trades at 97,700 KRW, while our model-based Fair Value estimate is 177,268 KRW — implying the stock looks roughly 81.4% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Miwon Specialty Chemical Co., Ltd. engages in the manufacture and sales of energy-curing resins in Korea and internationally. The company is headquartered in Wanju-gun, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Miwon Specialty Chemical Co (268280) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 177,268 KRW versus a price of 97,700 KRW — about +81% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 268280?
Our 21-model fair value for Miwon Specialty Chemical Co is 177,268 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 97,700 KRW.
What is the quality score of 268280?
Miwon Specialty Chemical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.